General Information of the Protein
Protein ID
PT03027
Protein Name
Bromodomain-containing protein 9
Secondarily
Protein Name
Rhabdomyosarcoma antigen MU-RMS-40.8
Gene Name
BRD9
Secondarily
Gene Name
UNQ3040/PRO9856
Sequence
MGKKHKKHKAEWRSSYEDYADKPLEKPLKLVLKVGGSEVTELSGSGHDSSYYDDRSDHERERHKEKKKKKKKKSEKEKHLDDEERRKRKEEKKRKREREHCDTEGEADDFDPGKKVEVEPPPDRPVRACRTQPAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKQAALLGNEDTAVEEPVPEVVPVQVETAKKSKKPSREVISCMFEPEGNACSLTDSTAEEHVLALVEHAADEARDRINRFLPGGKMGYLKRNGDGSLLYSVVNTAEPDADEEETHPVDLSSLSSKLLPGFTTLGFKDERRNKVTFLSSATTALSMQNNSVFGDLKSDEMELLYSAYGDETGVQCALSLQEFVKDAGSYSKKVVDDLLDQITGGDHSRTLFQLKQRRNVPMKPPDEAKVGDTLGDSSSSVLEFMSMKSYPDVSVDISMLSSLGKVKKELDPDDSHLNLDETTKLLQDLHEAQAERGGSRPSSNLSSLSNASERDQHHLGSPSRLSVGEQPDVTHDPYEFLQSPEPAASAKT
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Epigenetic regulator
>
Reader
>
Bromodomain
Function
Plays a role in chromatin remodeling and regulation of transcription (PubMed:22464331, PubMed:26365797). Acts as a chromatin reader that recognizes and binds acylated histones: binds histones that are acetylated and/or butyrylated (PubMed:26365797). Component of SWI/SNF chromatin remodeling subcomplex GBAF that carries out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner (PubMed:29374058). Orchestrates also the RAD51-RAD54 complex formation and thereby plays a role in homologous recombination (HR) (PubMed:32457312).
    Show/Hide
Uniprot ID
Primary ID:
Q9H8M2

Secondarily ID:
A6NFY8
B4DMQ2
B4DR93
Q2XUS1
Q6UWU9
Q8IUS4
Q9H5Q5
Q9H7R9
    Show/Hide
Ensembl ID
ENSG00000028310
HGNC ID
HGNC:25818
Subcellular Location
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000059 , HuT 78
Compound ID Compound Name Compound Formula
CP0717935
rac-8-(((3R,4R)-3-((1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-methoxy)piperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)quinolin-2(1H)-one
   Show/Hide
C27H34N4O4S
 1
1
Kd = 1258.93 nM
   TI
   LI
   LO
   TS
CP0199056
8-[[(3R,4R)-3-(cyclohexylmethoxy)piperidin-4-yl]amino]-3-methyl-5-(5-methylpyridin-3-yl)-1H-1,7-naphthyridin-2-one
   Show/Hide
C27H35N5O2
 1
1
Kd = 15848.93 nM
   TI
   LI
   LO
   TS
CP0651910
8-(((3R,4R)-3-((1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-methoxy)-1-methylpiperidin-4-yl)amino)-3-methyl-5-(5-methylpyridin-3-yl)-1,7-naphthyridin-2(1H)-one
   Show/Hide
C27H35N5O4S
 1
1
Kd = 15848.93 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0033068
N'-(1,1-dioxothian-4-yl)-5-ethyl-4-oxo-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
   Show/Hide
C22H22F3N3O3S2
 4
1 IC50 = 10.4 nM
2 IC50 = 50.1 nM
3 IC50 = 50.12 nM
4 Kd = 1.995 nM
CP0055678
N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide
   Show/Hide
C26H30ClN3O4S
 2
1 Kd = 99 nM
2 Kd = 100 nM
Clinical Information about the Protein
Target 1 ( Bromodomain-containing protein 9 (BRD9) )
Target Type Literature-reported Target
Disease 1 Target-related Disease  1
1 Acute myeloid leukaemia [ICD-11: 2A60]
Investigative Drug(s) 1 Investigative Drug  1
1 BI 7273 Investigative
Acute myeloid leukaemia